 |
Charles G. Beever New York |
A New York-based Partner, Charley Beever leads Booz & Company's efforts to serve pharmaceutical clients worldwide. He has more than 20 years of experience working with leading U.S., European, and Japan-based pharmaceutical, biotechnology, diagnostic, health care, and medical device/supply companies to resolve strategic, organizational, and performance improvement issues.
Mr. Beever works with clients on engagements that involve:
-
Business strategy and growth
-
Sales and marketing productivity improvement
-
Organizational and operational performance improvement and business process redesign
-
Major merger integration planning and implementation
With a focus on the health and biotechnology sectors, some of his significant strategy and growth assignments have included:
-
Addressing health industry channel strategy, including the evolution of pharmaceutical benefit managers (PBMs), retailers, and managed care organizations
-
Growth opportunities assessment and a new product launch strategy for a major biotech company
-
Consultations on strategic business growth, diversification, and acquisition due diligence issues that have resulted in major acquisitions and strategic alliances
-
Strategy review for a leading European pharmaceutical company
-
Market and technology due diligence assessments to address new cancer therapies and medical devices for less-invasive surgery
-
Consultations with medical products distributors to assess the provision of new services to hospitals
Mr. Beever received Booz & Company's Professional Excellence Award in recognition of his exceptional and innovative client service on assignments for Quest Diagnostics and an HIV/AIDS epidemic strategic simulation.
A recognized thought leader, Mr. Beever has contributed to many publications, including the following strategy+business articles: “U.S. Health Care’s Technology Cost Crisis,” "The Prescription for Drug Costs,” “What’s Driving Prescription Drug Costs?,” and “Patient Safety: A Data-Driven Prescription,” and the IN VIVO magazine article "Competing in a Retail Health Consumer Marketplace."
Mr. Beever also was involved in the Booz & Company studies: “The Global AIDS Crisis—A Strategic Simulation to Explore Public/Private Partnerships in the Fight against HIV/AIDS” and “The Cost of Medical Technologies—Maximizing the Value of Innovation."
Mr. Beever holds an M.B.A. from the Harvard Graduate School of Business Administration and a B.A. in economics from Haverford College, where he was elected to Phi Beta Kappa.
